Physician profile
Caple A Spence
NPI 1134157340
$31,102.17
in general payments reported to CMS, 2019-2025
12 companies · $4,274 in 2025
The $4,274 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,260 · 2021: $13K · 2022: $1,400 · 2023: $2,679 · 2024: $1,442 · 2025: $4,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,644 · Consulting Fee: $3,200 · Food and Beverage: $1,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,643.82 |
| Consulting Fee | $3,200.00 |
| Food and Beverage | $1,551.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $26,083.90 | 2019-2025 | Testa Tp Pivoting Spacer System |
| Stryker Corporation | $3,119.48 | 2023-2025 | Everest Spinal System, Chromophare F300, N/A |
| Karl Storz Endoscopy-America | $1,373.87 | 2025 | |
| Centinel Spine, LLC | $172.40 | 2023 | Prodisc C Vivo |
| Icotec Medical INC. | $107.05 | 2023 | Icotec Blackarmor Spine System |
| Carlsmed, INC. | $80.92 | 2025 | Aprevo |
| Intrinsic Therapeutics | $45.01 | 2021 | |
| Boston Scientific Corporation | $31.50 | 2024 | Wavewriter Alpha Prime 16 |
| Ebi, LLC | $26.88 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Si-Bone, INC. | $23.91 | 2025 | |
| Orthofix Medical, INC. | $21.81 | 2024 | Spinal-Stim, Cervical-Stim |
| Medtronic, INC. | $15.44 | 2023 | Unid_pass |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caple Spence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.